The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, M.
Right arrow Articles by Fairchild, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, M.
Right arrow Articles by Fairchild, R. L.
The Journal of Immunology, 2001, 167: 3494-3504.
Copyright © 2001 by The American Association of Immunologists

Monokine Induced by IFN-{gamma} Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts During Acute Rejection1

Masayoshi Miura2,*,{dagger}, Ken Morita*, Hirohito Kobayashi*, Thomas A. Hamilton{dagger}, Marie D. Burdick{ddagger}, Robert M. Strieter{ddagger} and Robert L. Fairchild2,*,{dagger},§

* Urological Institute and {dagger} Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195; {ddagger} Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, CA 90095; and § Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106

The use of chemokine antagonism as a strategy to inhibit leukocyte trafficking into inflammatory sites requires identification of the dominant chemokines mediating recruitment. The chemokine(s) directing T cells into cardiac allografts during acute rejection remain(s) unidentified. The role of the CXC chemokines IFN-{gamma} inducible protein 10 (IP-10) and monokine induced by IFN-{gamma} (Mig) in acute rejection of A/J (H-2a) cardiac grafts by C57BL/6 (H-2b) recipients was tested. Intra-allograft expression of Mig was observed at day 2 posttransplant and increased to the time of rejection at day 7 posttransplant. IP-10 mRNA and protein production were 2.5- to 8-fold lower than Mig. Whereas allografts were rejected at day 7–9 in control recipients, treatment with rabbit antiserum to Mig, but not to IP-10, prolonged allograft survival up to day 19 posttransplant. At day 7 posttransplant, allografts from Mig antiserum-treated recipients had marked reduction in T cell infiltration. At the time of rejection in Mig antiserum-treated recipients (i.e., days 17–19), intra-allograft expression of macrophage-inflammatory protein-1{alpha}, -1{beta}, and their ligand CCR5 was high, whereas expression of CXCR3, the Mig receptor, was virtually absent. Mig was produced by the allograft endothelium as well as by recipient allograft-infiltrating macrophages and neutrophils, indicating the synergistic interactions between innate and adaptive immune compartments during acute rejection. Collectively, these results indicate that Mig is a dominant recruiting factor for alloantigen-primed T cells into cardiac allografts during acute rejection. Although Mig antagonism delays acute heart allograft rejection, the results also suggest that the alloimmune response circumvents Mig antagonism through alternative mechanisms.




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. A Belperio and A. Ardehali
Chemokines and Transplant Vasculopathy
Circ. Res., August 29, 2008; 103(5): 454 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. S. Yolcu, X. Gu, C. Lacelle, H. Zhao, L. Bandura-Morgan, N. Askenasy, and H. Shirwan
Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein
J. Immunol., July 15, 2008; 181(2): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhang, Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein
CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis
J. Immunol., February 15, 2008; 180(4): 2641 - 2649.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kwun, H. Hu, E. Schadde, D. Roenneburg, K. A. Sullivan, J. DeMartino, W. J. Burlingham, and S. J. Knechtle
Altered Distribution of H60 Minor H Antigen-Specific CD8 T Cells and Attenuated Chronic Vasculopathy in Minor Histocompatibility Antigen Mismatched Heart Transplantation in Cxcr3 / Mouse Recipients
J. Immunol., December 15, 2007; 179(12): 8016 - 8025.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Schroder, R. N. Pierson III, B.-N. H. Nguyen, D. W. Kawka, L. B. Peterson, G. Wu, T. Zhang, M. S. Springer, S. J. Siciliano, S. Iliff, et al.
CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates
J. Immunol., August 15, 2007; 179(4): 2289 - 2299.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Gorbachev, H. Kobayashi, D. Kudo, C. S. Tannenbaum, J. H. Finke, S. Shu, J. M. Farber, and R. L. Fairchild
CXC Chemokine Ligand 9/Monokine Induced by IFN-{gamma} Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors
J. Immunol., February 15, 2007; 178(4): 2278 - 2286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. D. Medoff, J. C. Wain, E. Seung, R. Jackobek, T. K. Means, L. C. Ginns, J. M. Farber, and A. D. Luster
CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function.
J. Immunol., June 1, 2006; 176(11): 7087 - 7095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yuan, R. El-Asady, K. Liu, D. Wang, C. B. Drachenberg, and G. A. Hadley
Critical Role for CD103+CD8+ Effectors in Promoting Tubular Injury following Allogeneic Renal Transplantation
J. Immunol., September 1, 2005; 175(5): 2868 - 2879.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Tanaka, R.-J. Swijnenburg, F. Gunawan, Y.-A. Cao, Y. Yang, A. D. Caffarelli, J. L. de Bruin, C. H. Contag, and R. C. Robbins
In Vivo Visualization of Cardiac Allograft Rejection and Trafficking Passenger Leukocytes Using Bioluminescence Imaging
Circulation, August 30, 2005; 112(9_suppl): I-105 - I-110.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. El-Sawy, J. A. Belperio, R. M. Strieter, D. G. Remick, and R. L. Fairchild
Inhibition of Polymorphonuclear Leukocyte-Mediated Graft Damage Synergizes With Short-Term Costimulatory Blockade to Prevent Cardiac Allograft Rejection
Circulation, July 19, 2005; 112(3): 320 - 331.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. A. Hauser, S. Spiegler, E. Kiss, S. Gauer, O. Sichler, E. H. Scheuermann, H. Ackermann, J. M. Pfeilschifter, H. Geiger, H.-J. Grone, et al.
Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-{gamma} (MIG)
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1849 - 1858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild
Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts
J. Immunol., May 15, 2005; 174(10): 6499 - 6508.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Singbartl, S. G.{b.}e Bockhorn, A. Zarbock, M. Schmolke, and H. Van Aken
T Cells Modulate Neutrophil-Dependent Acute Renal Failure during Endotoxemia: Critical Role for CD28
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 720 - 728.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Tanaka, S. Nakae, R. D. Terry, G. K. Mokhtari, F. Gunawan, L. B. Balsam, H. Kaneda, T. Kofidis, P. S. Tsao, and R. C. Robbins
Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease
Blood, December 1, 2004; 104(12): 3789 - 3796.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Engeman, A. V. Gorbachev, D. D. Kish, and R. L. Fairchild
The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites
J. Leukoc. Biol., November 1, 2004; 76(5): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
G. VALBUENA and D. H. WALKER
EFFECT OF BLOCKING THE CXCL9/10-CXCR3 CHEMOKINE SYSTEM IN THE OUTCOME OF ENDOTHELIAL-TARGET RICKETTSIAL INFECTIONS
Am J Trop Med Hyg, October 1, 2004; 71(4): 393 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. C. Hildebrandt, L. A. Corrion, K. M. Olkiewicz, B. Lu, K. Lowler, U. A. Duffner, B. B. Moore, W. A. Kuziel, C. Liu, and K. R. Cooke
Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome
J. Immunol., August 1, 2004; 173(3): 2050 - 2059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Colvin, G. S. V. Campanella, J. Sun, and A. D. Luster
Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function
J. Biol. Chem., July 16, 2004; 279(29): 30219 - 30227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. El-Sawy, M. Miura, and R. Fairchild
Early T Cell Response to Allografts Occuring Prior to Alloantigen Priming Up-Regulates Innate-Mediated Inflammation and Graft Necrosis
Am. J. Pathol., July 1, 2004; 165(1): 147 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Whiting, G. Hsieh, J. J. Yun, A. Banerji, W. Yao, M. C. Fishbein, J. Belperio, R. M. Strieter, B. Bonavida, and A. Ardehali
Chemokine Monokine Induced by IFN-{gamma}/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production
J. Immunol., June 15, 2004; 172(12): 7417 - 7424.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Kondo, K. Ohmori, A. Oshita, H. Takeuchi, J. Yoshida, K. Shinomiya, S. Fuke, T. Suzuki, K. Mizushige, and M. Kohno
Leukocyte-Targeted Myocardial Contrast Echocardiography Can Assess the Degree of Acute Allograft Rejection in a Rat Cardiac Transplantation Model
Circulation, March 2, 2004; 109(8): 1056 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. L. Colvin, A. E. Morelli, A. J. Logar, A. H. Lau, and A. W. Thomson
Comparative evaluation of CC chemokine-induced migration of murine CD8{alpha}+ and CD8{alpha}- dendritic cells and their in vivo trafficking
J. Leukoc. Biol., February 1, 2004; 75(2): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Abdi, T. K. Means, T. Ito, R. N. Smith, N. Najafian, M. Jurewicz, V. Tchipachvili, I. Charo, H. Auchincloss Jr., M. H. Sayegh, et al.
Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo
J. Immunol., January 15, 2004; 172(2): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Richards, S. L. Dalheimer, M. I. Hertz, and D. L. Mueller
Trachea Allograft Class I Molecules Directly Activate and Retain CD8+ T Cells That Cause Obliterative Airways Disease
J. Immunol., December 15, 2003; 171(12): 6919 - 6928.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter
Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection
J. Immunol., November 1, 2003; 171(9): 4844 - 4852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Valbuena, W. Bradford, and D. H. Walker
Expression Analysis of the T-Cell-Targeting Chemokines CXCL9 and CXCL10 in Mice and Humans with Endothelial Infections Caused by Rickettsiae of the Spotted Fever Group
Am. J. Pathol., October 1, 2003; 163(4): 1357 - 1369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Ichiba, T. Teshima, R. Kuick, D. E. Misek, C. Liu, Y. Takada, Y. Maeda, P. Reddy, D. L. Williams, S. M. Hanash, et al.
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays
Blood, July 15, 2003; 102(2): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q.-W. Zhang, D. D. Kish, and R. L. Fairchild
Absence of Allograft ICAM-1 Attenuates Alloantigen-Specific T Cell Priming, But Not Primed T Cell Trafficking into the Graft, to Mediate Acute Rejection
J. Immunol., June 1, 2003; 170(11): 5530 - 5537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Miura, T. El-Sawy, and R. L. Fairchild
Neutrophils Mediate Parenchymal Tissue Necrosis and Accelerate the Rejection of Complete Major Histocompatibility Complex-Disparate Cardiac Allografts in the Absence of Interferon-{gamma}
Am. J. Pathol., February 1, 2003; 162(2): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jiankuo, W. Xingbing, H. Baojun, W. Xiongwin, L. Zhuoya, X. Ping, X. Yong, L. Anting, H. Chunsong, G. Feili, et al.
Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft
J. Immunol., February 1, 2003; 170(3): 1556 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Bek, H. C. Reinhardt, K.-G. Fischer, J. R. Hirsch, C. Hupfer, E. Dayal, and H. Pavenstadt
Up-Regulation of Early Growth Response Gene-1 Via the CXCR3 Receptor Induces Reactive Oxygen Species and Inhibits Na+/K+-ATPase Activity in an Immortalized Human Proximal Tubule Cell Line
J. Immunol., January 15, 2003; 170(2): 931 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Feng, D. Wang, R. Yuan, C. M. Parker, D. L. Farber, and G. A. Hadley
CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8+ T Cells
J. Exp. Med., October 7, 2002; 196(7): 877 - 886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. J. Yun, M. P. Fischbein, D. Whiting, Y. Irie, M. C. Fishbein, M. D. Burdick, J. Belperio, R. M. Strieter, H. Laks, J. A. Berliner, et al.
The Role of MIG/CXCL9 in Cardiac Allograft Vasculopathy
Am. J. Pathol., October 1, 2002; 161(4): 1307 - 1313.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Abdi, R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. Auchincloss Jr., and M. H. Sayegh
The Role of CC Chemokine Receptor 5 (CCR5) in Islet Allograft Rejection
Diabetes, August 1, 2002; 51(8): 2489 - 2495.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Park, D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al.
The CXC Chemokine Murine Monokine Induced by IFN-{gamma} (CXC Chemokine Ligand 9) Is Made by APCs, Targets Lymphocytes Including Activated B Cells, and Supports Antibody Responses to a Bacterial Pathogen In Vivo
J. Immunol., August 1, 2002; 169(3): 1433 - 1443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. X.-M. Zhao, Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby
Differential Expression of the IFN-{gamma}-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell {alpha} Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection
J. Immunol., August 1, 2002; 169(3): 1556 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Strieter
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
J. Immunol., July 15, 2002; 169(2): 1037 - 1049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.